Zhang Ensheng, Chen Qian, Wang Jing, Li Dong, Wan Zhenxia, Ju Xiuli
Department of Pediatrics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China; Department of Pediatrics, Maternal and Child Health Care Hospital of Shandong Province, Cheeloo College of Medicine, Jinan 250014, Shandong, China.
Department of Pediatrics, Maternal and Child Health Care Hospital of Shandong Province, Cheeloo College of Medicine, Jinan 250014, Shandong, China.
Int Immunopharmacol. 2020 Sep;86:106635. doi: 10.1016/j.intimp.2020.106635. Epub 2020 Jul 4.
MicroRNAs (miRNAs) have been reported in cerebral ischemia-reperfusion injury, yet the function of miR-27a in it has seldom been mentioned. This study aims to assess the mechanisms of miR-27a in rats with cerebral ischemia-reperfusion injury.
The cerebral ischemia-reperfusion models of rat pups were established by bilateral carotid artery occlusion. Rats were treated with miR-27a agomir, silenced HSP90 expression plasmids or PI3K/AKT/mTOR pathway agonist. Oxidative stress indices, inflammatory factors, brain tissue water content, cerebral infarct volume, neurological function score and neuronal apoptosis in rats with cerebral ischemia-reperfusion injury were measured. MiR-27a and HSP90 expression and PI3K/AKT/mTOR phosphorylation levels in the brain tissues of rats were also detected.
MiR-27a expression and PI3K/AKT/mTOR phosphorylation levels were downregulated while HSP90 expression was upregulated in cerebral ischemia-reperfusion injury rats. Elevated miR-27a or reduced HSP90 diminished water content, neuronal apoptosis and infarct volume, suppressed oxidative stress and inflammatory response, as well as improved neurological deficits and pathological damages. Moreover, elevated miR-27a or silenced HSP90 upregulated PI3K/AKT/mTOR phosphorylation levels in cerebral ischemia-reperfusion injury rats. HSP90 silencing or PI3K/AKT/mTOR pathway agonist reversed the unfavorable effects of low miR-27a expression on cerebral ischemia-reperfusion injury rats.
To conclude, our study demonstrates that elevated miR-27a or decreased HSP90 attenuates oxidative stress and inflammatory response, and improves neurological function in cerebral ischemia-reperfusion injury rats by activating PI3K/AKT/mTOR signaling pathway.
已有研究报道微小RNA(miRNA)与脑缺血再灌注损伤有关,但很少提及miR-27a在其中的作用。本研究旨在评估miR-27a在大鼠脑缺血再灌注损伤中的作用机制。
通过双侧颈总动脉闭塞建立幼鼠脑缺血再灌注模型。大鼠分别接受miR-27a激动剂、沉默HSP90表达质粒或PI3K/AKT/mTOR通路激动剂治疗。检测脑缺血再灌注损伤大鼠的氧化应激指标、炎症因子、脑组织含水量、脑梗死体积、神经功能评分及神经元凋亡情况。同时检测大鼠脑组织中miR-27a和HSP90的表达以及PI3K/AKT/mTOR的磷酸化水平。
脑缺血再灌注损伤大鼠中miR-27a表达及PI3K/AKT/mTOR磷酸化水平下调,而HSP90表达上调。上调miR-27a或降低HSP90可减少含水量、神经元凋亡及梗死体积,抑制氧化应激和炎症反应,改善神经功能缺损及病理损伤。此外,上调miR-27a或沉默HSP90可上调脑缺血再灌注损伤大鼠PI3K/AKT/mTOR磷酸化水平。沉默HSP90或使用PI3K/AKT/mTOR通路激动剂可逆转低miR-27a表达对脑缺血再灌注损伤大鼠的不利影响。
综上所述,我们的研究表明上调miR-27a或降低HSP90可通过激活PI3K/AKT/mTOR信号通路减轻脑缺血再灌注损伤大鼠的氧化应激和炎症反应,改善神经功能。